Academia
As the pandemic progresses, researchers are attacking the virus from every angle, and also learning more and more about how and why the virus affects who it does.
Keele, UK, 31 March 2020: Cobra Biologics, an international CDMO for biologics and pharmaceuticals, announced it is working as part of a consortium led by the Jenner Institute, Oxford University to rapidly develop, scale-up and produce the potential adenoviral vaccine candidate, ChAdOx1 nCov-19, for fast-tracked clinical trials for COVID-19.
This Clinical Catch-Up has been split into three sections: COVID-19-Related Clinical Trials; Non-COVID-19-Related Clinical Trials; and Trials Affected by the COVID-19 Pandemic. Here’s a look.
When tested in mice, the vaccine, which is delivered through a fingertip-sized patch, produced the antibodies specific to the novel coronavirus that causes COVID-19.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Doudna announced she is converting a 2,500-square-foot scientific lab at Berkeley’s Innovative Genomics Institute into a lab for testing for the novel coronavirus that causes COVID-19.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
Washington University School of Medicine in St. Louis released a new study about the effectiveness of immunotherapy based on the age of the cells used.
Four separate research groups in the U.S., Australia and China analyzed how temperature and humidity affect the coronavirus and they predict that hot summer months could decrease the presence of the virus in the Northern Hemisphere.
Malaria Drug and Antibiotic Combo May Work Against COVID-19, But Experts Warn Caution and Skepticism
French researchers have published an article describing the potential use of a combination of hydroxychloroquine and the antibiotic azithromycin. The U.S. Food and Drug Administration is also evaluating the drugs but have not yet made recommendations.
PRESS RELEASES